Skip to main content
Clinical Trials/IRCT20180608040013N2
IRCT20180608040013N2
Recruiting
Phase 1

Investigation of the effect of Midazolam prophylaxis on the incidence of idiosyncratic seizures caused by tramadol consumption

Shiraz University of Medical Sciences0 sites28 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Seizures.
Sponsor
Shiraz University of Medical Sciences
Enrollment
28
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Take tramadol tablets for the past 6 hours
  • Age over 16 years
  • No seizures before entering the study

Exclusion Criteria

  • Age over 70 years
  • History of epilepsy
  • Concomitant use of antidepressants
  • Concomitant use of other drugs with a dose of poisoning
  • History of underlying diseases
  • Trauma to the head

Outcomes

Primary Outcomes

Not specified

Similar Trials